The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product & drug development various small innovative players are operating in the market.
However, inadequate research and regulatory policies in the human microbiome are some of the factors which restrain the progress. Learn about microbial innovation and applying the new microbiome findings along with the regulatory pathways for better therapeutic development. Also, witness discussions on microbiome vs probiotics and the link between them.
Connect with biotech, pharma, academicians and investors at 5th Annual Next Gen Microbiome and Probiotics Conference on 9-10 February 2023 in San Diego, USA, discussing the most ingenious research and technological advances. Key sessions on effective microbiome therapeutics in production, regulatory pathways, prebiotics probiotics and postbiotics along with discussion on effective translation from R&D to commercialization.
Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations from the departments of:
Directors, Heads, Professors/Assistant Professors/ Associate Professor, Research Scholars, Scientists from the departments of: